Anti-programmed death 1 antibody in the treatment of coexistent Mycobacterium fortuitum and lung cancer: A case report

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 12

Peer-Review Report of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Apr 26, 2022; 10(12): 3801-3807
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3801

Full Size Figure Download Figure

Figure 3 Pathology diagnosis of the second biopsy (× 400). A: Carbon dust deposition; B: Invasion of lymph cells; C: Fibrosis.

Citation: Zhang CC, Chen P. Anti-programmed death 1 antibody in the treatment of coexistent Mycobacterium fortuitum and lung cancer: A case report. World J Clin Cases 2022; 10(12): 3801-3807
URL: https://www.wjgnet.com/2307-8960/full/v10/i12/3801.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i12.3801

Zhang CC, Chen P. Anti-programmed death 1 antibody in the treatment of coexistent Mycobacterium fortuitum and lung cancer: A case report. World J Clin Cases 2022; 10(12): 3801-3807 [PMID: 35647142 DOI: 10.12998/wjcc.v10.i12.3801]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.